Suppression of Wnt/β-catenin and RAS/ERK pathways provides a therapeutic strategy for gemcitabine-resistant pancreatic cancer

Won Ji Ryu, Gyoonhee Han, Soung Hoon Lee, Kang Yell Choi

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Suppression of Wnt/β-catenin and RAS/ERK pathways provides a therapeutic strategy for gemcitabine-resistant pancreatic cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds